Your browser doesn't support javascript.
loading
Treatment Strategy for Patients with HR-Positive HER2-Negative Metastatic Breast Cancer That Progressed on CDK4/6 Inhibitors.
Hayama, Shouko; Nakamura, Rikiya; Miyaki, Toshiko; Itami, Makiko; Yamamoto, Naohito.
Afiliação
  • Hayama S; Department of Breast Surgery, Chiba Cancer Center, Chiba, Japan.
  • Nakamura R; Department of Breast Surgery, Chiba Cancer Center, Chiba, Japan.
  • Miyaki T; Department of Breast Surgery, Chiba Cancer Center, Chiba, Japan.
  • Itami M; Division of Diagnostic Pathology, Chiba Cancer Center, Chiba, Japan.
  • Yamamoto N; Department of Breast Surgery, Chiba Cancer Center, Chiba, Japan.
Breast Care (Basel) ; 17(1): 16-23, 2022 Feb.
Article em En | MEDLINE | ID: mdl-35355705

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article